Structure Therapeutics Inc (GPCR) ADR Each Representing 3 Ord Shares

Sell:$32.41Buy:$34.66$1.03 (3.24%)

Prices delayed by at least 15 minutes
Sell:$32.41
Buy:$34.66
Change:$1.03 (3.24%)
Prices delayed by at least 15 minutes
Sell:$32.41
Buy:$34.66
Change:$1.03 (3.24%)
Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
10 June 2024
Raymond C StevensCEO
Sell
Regular sell transaction (market)
185,000$52.80$9,767,352.500
3 June 2024
Xichen LinChief Level Officer
Sell
Option/Award related
17,700$45.00$796,500.0017,700
3 June 2024
Xichen LinChief Level Officer
Sell
Option/Award related
17,700$50.00$885,070.800
5 December 2023
FIL LTDAsset Management Company
Sell
Regular sell transaction (market)
16,086$62.46$1,004,731.5632,169
5 December 2023
FIL LTDAsset Management Company
Sell
Regular sell transaction (market)
1,368$62.46$85,445.282,733

End of results. Director deals are only available for the last 12 months.

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
10 June 2024
Raymond C StevensCEO
Sell
Regular sell transaction (market)
185,000$52.80$9,767,352.500
5 December 2023
FIL LTDAsset Management Company
Sell
Regular sell transaction (market)
16,086$62.46$1,004,731.5632,169
3 June 2024
Xichen LinChief Level Officer
Sell
Option/Award related
17,700$50.00$885,070.800
3 June 2024
Xichen LinChief Level Officer
Sell
Option/Award related
17,700$45.00$796,500.0017,700
5 December 2023
FIL LTDAsset Management Company
Sell
Regular sell transaction (market)
1,368$62.46$85,445.282,733

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.